Results 221 to 230 of about 14,357 (275)

DESMOPRESSIN AND ANTIFIBRINOLYTICS

International Anesthesiology Clinics, 1990
Desmopressin appears to be a safe and effective hemostatic agent for use during surgery in patients with mild to moderate hemophilia or von Willebrand disease. Uremic patients also benefit from substitution of desmopressin for cryoprecipitate to control bleeding. The highly variable response to desmopressin by individual patients with hemophilia or von
openaire   +2 more sources

Antifibrinolytic Treatment in Subarachnoid Hemorrhage

New England Journal of Medicine, 1984
We enrolled 479 patients with subarachnoid hemorrhage in a multicenter, randomized, double-blind, placebo-controlled trial to determine whether treatment with the antifibrinolytic agent tranexamic acid improves outcome by preventing rebleeding. At three months there was no statistical difference between the outcomes in the tranexamic acid group and the
Vermeulen, M., Lindsay, K. W., Murray, G. D., Cheah, F., Hijdra, A., Muizelaar, J. P., Schannong, M., Teasdale, G. M., van Crevel, H., van Gijn, J.   +9 more
openaire   +2 more sources

Cimetidine—an Antifibrinolytic Agent?

Scandinavian Journal of Gastroenterology, 1983
The mucosal fibrinolytic activity was estimated in 14 patients with duodenal ulcer before and after 4 weeks' treatment with cimetidine. A significant reduction in fibrinolytic activity in the corpus and antrum mucosa was found after treatment. In patients with healed ulcer after treatment, the activity was lower than in patients with unhealed ulcers ...
openaire   +2 more sources

Antifibrinolytic Therapy-Reply

Archives of Neurology, 1982
In Reply.— We thank Dr Vermeulen and his associates for their comments. The effectiveness of antifibrinolytic therapy has not been unequivocally proved. The whole subject has been recently reviewed. 1 Much of the controversy about the value of antifibrinolytic therapy has resulted from problems in methods. None of the studies (including ours), whether
H. P. Adams, A. L. Sahs, J. Torner
openaire   +1 more source

Antifibrinolytics for heavy menstrual bleeding

Cochrane Database of Systematic Reviews, 2000
Heavy menstrual bleeding (HMB) is an important cause of ill health in women. Medical therapy, with the avoidance of possibly unnecessary surgery, is an attractive treatment option. A wide variety of medications are available to reduce heavy menstrual bleeding but there is considerable variation in practice and uncertainty about the most appropriate ...
I, Cooke, A, Lethaby, C, Farquhar
openaire   +3 more sources

Antifibrinolytic Activity of Certain Pectins

Thrombosis and Haemostasis, 1961
SummaryIngestion of wine and beer, but not of ethyl alcohol, produced a decrease of the blood fibrinolytic activity. In vitro experiments showed that wine and beer contained a principle which inhibited fibrinolytic activators. This principle was isolated from grape pulp, and upon analysis it was found to be a pectin-like substance.
I M, NILSSON, S E, BJORKMAN, , von STUDNITZ, A, HALLEN   +3 more
openaire   +2 more sources

Antifibrinolytics in Subarachnoid Hemorrhage

Archives of Neurology, 1987
Few conditions evince potential for disaster or cure as vividly as subarachnoid hemorrhage. If the patient survives the initial bleeding intact or with minor deficits, clipping of the aneurysm virtually eliminates the risk of recurrence. However, before something definite can be done, the patient faces the risk of rebleeding and later that of vasospasm.
openaire   +2 more sources

Antifibrinolytics and Thrombolytics

2018
There is a balance between activation of the coagulation cascade leading to thrombin and the fibrinolytic system dissolving clots. Antifibrinolytic drugs and fibrinolytic drugs are commonly used in the neurosciences intensive care unit. Antifibrinolytics, mostly tranexamic acid, are used to prevent rebleeding of recently ruptured intracranial aneurysms
Eelco F. M. Wijdicks, Sarah L. Clark
openaire   +1 more source

Antithrombotics and Antifibrinolytics

2014
Pediatric thromboembolic events are rare, but the incidence of thrombosis in children has dramatically increased over the last decade and appears to be an increasing problem in pediatric tertiary care hospitals. They usually occur as a complication of a primary disease or treatment.
Donald Berry, Sriya Gunawardena
openaire   +1 more source

Antifibrinolytic agents in subarachnoid haemorrhage

Journal of Neurology, 1987
For many years clinicians have used antifibrinolytic agents to try to reduce rebleeding after subarachnoid haemorrhage. Early studies of their effectiveness produced conflicting results. This paper re-evaluates the available trials and considers benefits in the light of potential complications.
openaire   +2 more sources